Product Information
HEPARIN SODIUM 5,000 UNIT/ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $1.1796 per ML under NDC 63323026236. Its NADAC has been published 248 times since Jan 5, 2022.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
5000 [USP'U]/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323026236
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
HEPARIN SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA017029FDA Approved
Before 1982
TE Code
AP
On Market Since
3/2/2020
Pharmacological Classes
Price Statistics
The NADAC for HEPARIN SODIUM 5,000 UNIT/ML VIAL has been published 248 times since Jan 5, 2022, and over the history we have for it it has declined 14.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1796 per ML |
|---|---|
| All-time high | $1.8026 (Feb 14, 2024) |
| All-time low | $1.0430 (Nov 19, 2025) |
| 52-week high | $1.2024 |
| 52-week low | $1.0430 |
| Median price | $1.1987 |
| Average price | $1.3347 |
| Largest weekly change | -35.3% (Feb 21, 2024) |
| Weeks tracked | 248 |
| Tracking since | Jan 5, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
HEPARIN SODIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-coagulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HEPARIN SODIUM 5,000 UNIT/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for HEPARIN SODIUM 5,000 UNIT/ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $1.1796 per ML (NDC 63323026236), effective Sep 30, 2026.
How has the price of HEPARIN SODIUM 5,000 UNIT/ML VIAL changed over time?
Over the history we have for it, the NADAC for HEPARIN SODIUM 5,000 UNIT/ML VIAL has declined 14.8%. It has been tracked across 248 weekly CMS publications since Jan 5, 2022.
What are the highest and lowest recorded NADAC prices for HEPARIN SODIUM 5,000 UNIT/ML VIAL?
Since Jan 5, 2022, the NADAC for HEPARIN SODIUM 5,000 UNIT/ML VIAL has ranged from a low of $1.0430 (Nov 19, 2025) to a high of $1.8026 (Feb 14, 2024), with a median of $1.1987 per ML.
Are there cheaper alternatives to HEPARIN SODIUM 5,000 UNIT/ML VIAL?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HEPARIN SODIUM 5,000 UNIT/ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures HEPARIN SODIUM 5,000 UNIT/ML VIAL?
HEPARIN SODIUM 5,000 UNIT/ML VIAL (NDC 63323026236) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.